Hundreds of millions of men and women worldwide suffer from osteoporosis. Increase in life expectancy, lifestyle and medications have made osteoporosis a growing epidemic. The world’s leading health organizations are investing in research aimed to improve the diagnosis, treatment and prevention of osteoporosis, also called the “silent thief”, and to raise awareness among the public. Preserving bone health is crucial for normal functioning and overall quality of life in advanced age.
Amorphical has acquired a deep knowledge and understanding of the molecular bio-mineralization processes of calcium that are being used in the development of potential future drugs based on amorphous calcium carbonate. These innovative drugs will offer treatment and prevention of diseases related with calcium and bone metabolism and improve the overall quality of life of many patients.
Amorphical is currently conducting a number of clinical studies aimed to test the efficacy of amorphous calcium carbonate in several indications. Additional studies are being designed and are expected to be launched in the near future.
We believe that the advantages of our unique amorphous calcium carbonate products will contribute greatly to the well-being of millions of people worldwide.